"Vi per Vida", a charity run by sommelier Xavi Ayala, promotes social awareness of the importance of research.
The event will be held this Sunday, February 25 in Calella.
On Sunday 25 February, the non-profit organisation “Vi per Vida” (Wine for Life), will be holding a new wine-tasting event for 300 people at the Llobet i Gurí Factory in Calella (Barcelona). The objective of this fundraising initiative is to draw public attention to the importance of research and to support research into cancer and metastasis conducted at Institute for Research in Biomedicine (IRB Barcelona). Metastasis is the term used to describe the spread of a primary tumour to distant organs, a process that causes 90% of deaths from cancer
This will be the tenth charity wine-tasting event organised by “Vi per vida”, an initiative run by the sommelier Xavier Ayala and which came about from his passion for wine and the heartfelt death of his father from lung cancer metastasis when Xavier was only nine years old.
"I have always wanted to make support research into metastasis, because of my father. I am very grateful for people’s response and to be able to contribute to strengthening the research conducted by a centre like IRB Barcelona," comments Xavier Ayala.
People interested in attending this event can buy tickets for 10€, which will allow them to taste five wines from various denominations of origin in Catalonia: Alella, Costers del Segre, Catalunya and Empordà.
Furthermore, tickets can be purchased in advance through Ticketea, at the Diagonal de Pineda Restaurant, and at three points of sale in Calella: Fruits secs Tulsà, Sapor d'Italia restaurant and the Bisbe Sivilla Institute.
IRB Barcelona researchers thank the “Vi per Vida” initiative
The newspapers Público and El Punt Avui,and the TV channel La Sexta, among other media, have reported on a recent study headed by Cayetano González, ICREA researcher at IRB Barcelona. Using the vinegar fly, Drosophila melanogaster, this study has identified possible regulators of the differences in tumours associated with the sex of an individual. Published in Science Advances, the study compares the brain tumours of male and female flies at the molecular level and identifies the protein responsible for the different degrees of aggressiveness.
An understanding of the molecular basis of differences in the incidence and survival of cancer between men and women may allow the discovery of specific and more effective treatments.
The study, published in Science Advances, compares the brain tumours of male and female flies at the molecular level and identifies proteins responsible for the different degree of aggressiveness.
The radio station COPE, the newspaper ABC, RTVE and the scientific news agency SINC, among other media, have echoed news about a study led by Xavier Salvatella, head of the Molecular Biophysics Laboratory at IRB Barcelona. This study indicates that chaperone protein Hps70 could be an attractive therapeutic target for the treatment of Kennedy’s disease, a rare neuromuscular disorder, as well as castration-resistant prostate cancer.
